IN
InterCure Ltd.
INCR · NASDAQ
$5.37 +1.90% (+$0.10)
1M -0.56%
Market Cap 195.3M ₪
P/E Ratio -
Div. Yield -
ROE 8.63%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.49x
P/FCF 8.00x
P/S 0.72x
Growth
0 /100
Declining FCF growth 25.01%
Book val. growth 7.52%
Rev. growth 11.41%
Profitability
22 /100
Weak FCF margin 9.04%
Op. margin 10.08%
Gross margin 15.06%
Quality
5 /100
Poor Asset turnover 0.39x
ROA 5.17%
ROIC 5.47%
Debt
82 /100
Low Current ratio 1.48x
Debt/Equity 0.46x
Net debt/EBITDA N/A
Stability
40 /100
Moderate Profitable years 0
EPS volatility 154.77%
Beta 0.60x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o INCR
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Alexander Rabinovich
Employees
285
Headquarters
Herzliya